scholarly journals Severe Topical Corticosteroid Withdrawal Syndrome from Over-the-Counter Steroids

Author(s):  
Anh P. Nguyen ◽  
James S. Kong ◽  
Suzanne S. Teuber
2017 ◽  
Vol 3 (5) ◽  
pp. 420-421 ◽  
Author(s):  
Julie Dhossche ◽  
Eric Simpson ◽  
Tamar Hajar

1988 ◽  
Vol 3 (4) ◽  
pp. 476-477 ◽  
Author(s):  
L. Verresen ◽  
Y. Vanrenterghem ◽  
M. Waer ◽  
D. Hauglustaine ◽  
P. Michielsen

1980 ◽  
Vol 68 (2) ◽  
pp. 224-230 ◽  
Author(s):  
Rosina B. Dixon ◽  
Nicholas P. Christy

2008 ◽  
Vol 35 (9) ◽  
pp. 601-603 ◽  
Author(s):  
Hidehisa SAEKI ◽  
Aya WATANABE ◽  
Yayoi TADA ◽  
Takashi KAKINUMA ◽  
Mayumi KOMINE ◽  
...  

2015 ◽  
Vol 72 (3) ◽  
pp. 541-549.e2 ◽  
Author(s):  
Tamar Hajar ◽  
Yael A. Leshem ◽  
Jon M. Hanifin ◽  
Susan T. Nedorost ◽  
Peter A. Lio ◽  
...  

2019 ◽  
Vol 17 (1) ◽  
pp. 73-75
Author(s):  
Mohan Bhusal ◽  
Eliz Aryal ◽  
Sabina Bhattarai ◽  
Sanju Babu Shrestha ◽  
Alark Rajouria

Corticosteroids are over the counter and cheaper drugs available in every medical stores in Nepal. Iatrogenic Cushing syndrome due to topical steroids application is a very rare phenomenon in adults.A 32 year female from Janakpur presented with complaints of swelling of face, weight gain, excessive facial hair and fatigue since two years that gradually increased over last one year. She had a past medical history of on and off application of multiple potent topical corticosteroids for disseminated Tinea infection. She was obese with moon facies, buffalo hump and multiple striae over her abdomen. Her blood pressure was raised and her blood sugar was in pre-diabetic range. Laboratory studies were consistent with iatrogenic Cushing syndrome. Patient recovered after discontinuation of topical corticosteroids and treatment with antifungals.Although iatrogenic Cushing syndrome following application of topical corticosteroid is a rare phenomenon in adults, this can happen in a setup like ours where corticosteroids are prescribed as over the counters and patients have very little knowledge about their use. Therefore, we emphasize that patients and pharmacist should be well educated about the consequences of their prolong application and their side effects


2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Serife Uzun ◽  
Zixi Wang ◽  
Tory A. McKnight ◽  
Paul Ehrlich ◽  
Erin Thanik ◽  
...  

Abstract Rationale We recently showed that multicomponent traditional Chinese medicine (TCM) therapy had steroid-sparing effects in moderate-to-severe eczema. We sought to evaluate TCM effects in severe eczema in a 7-year-old male with refractory disease and corticosteroid withdrawal syndrome. Methods Prior to referral, the patient had been treated since infancy with increasingly intensive standard of care, including high-dose topical and systemic corticosteroid and antibiotic therapy and was unable to tolerate further steroid treatment. The patient was administered a combination of oral and topical TCM for 17 months following discontinuation of his steroid regimen. His overall medical condition was assessed by SCORAD criteria and laboratory evaluations of serum IgE, absolute eosinophil count, and liver and kidney function tests. Results The patient showed rapid improvement of clinical measures of disease after starting TCM therapy, with marked improvement of sleep quality within the first week, complete resolution of itching, oozing, and erythema at 2 weeks, and a 79% and 99% decrease in his SCORAD values after one month and 3–6 months of TCM, respectively. Serum total IgE decreased by 75% (from 19,000 to 4630 (kIU/L), and absolute eosinophil counts decreased by 60% (from 1000 to 427 cells/μL) after 12 months of treatment. The patient did not require oral or topical steroids during the 17-month trial of TCM. TCM was tapered without complications. His dermatologic manifestations continued to be well-controlled 3 months after discontinuation. Conclusion This case study suggests TCM should be further evaluated in controlled clinical studies of patients with severe, refractory eczema and steroid withdrawal syndrome.


2021 ◽  
Vol 59 (12) ◽  
pp. 184-184

AbstractOverview of: Medicines and Healthcare products Regulatory Agency. Topical corticosteroids: information on the risk of topical steroid withdrawal reactions. Drug Safety Update 2021;15(2):1.


Sign in / Sign up

Export Citation Format

Share Document